These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 3245541)

  • 1. Vertical restraints among hospitals, physicians and health insurers that raise rivals' costs. A case study of Reazin v. Blue Cross and Blue Shield of Kansas, Inc. and Ocean State Physicians Health Plan, Inc. v. Blue Cross and Blue Shield of Rhode Island.
    Baker JB
    Am J Law Med; 1988; 14(2-3):147-69. PubMed ID: 3245541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimizing antitrust risks of Blue Cross and Blue Shield plans.
    Steele CJ
    J Contemp Health Law Policy; 1988; 4():227-72. PubMed ID: 10288422
    [No Abstract]   [Full Text] [Related]  

  • 3. "Blues interfered illegally with HMO.".
    Burda D
    Mod Healthc; 1987 Nov; 17(24):12. PubMed ID: 10284683
    [No Abstract]   [Full Text] [Related]  

  • 4. Ball Memorial Hospital: Section 2 Sherman Act analysis in the alternative health care delivery market.
    Kirsch T
    Am J Law Med; 1988; 14(2-3):249-79. PubMed ID: 3072878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Court overturns jury's verdict on Blue Cross antitrust violation claim.
    Kazon PM
    Bus Health; 1988 Nov; 6(1):44-5. PubMed ID: 10290529
    [No Abstract]   [Full Text] [Related]  

  • 6. Blues' discount policy seen as antitrust issue.
    Burda D
    Hospitals; 1986 Nov; 60(21):36. PubMed ID: 3770662
    [No Abstract]   [Full Text] [Related]  

  • 7. Court decisions give Blues plans one win, one loss in separate antitrust cases.
    Halper HR; Kazon PM
    Bus Health; 1987 Mar; 4(5):51-2. PubMed ID: 10280673
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment on Kartell v. Blue Shield of Massachusetts, Inc.: an antitrust analysis of Blue Shield's reimbursement schemes.
    Wayne AB
    Am J Law Med; 1986; 11(4):465-500. PubMed ID: 3591810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical care at predetermined prices does not violate antitrust laws.
    Rothschild IS
    Health Law Vigil; 1987 Apr; 10(9):5-6, 12. PubMed ID: 10281338
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitrust charges fail to slow PPA action by insurer.
    Burda D
    Hospitals; 1986 Apr; 60(8):68-70. PubMed ID: 3754236
    [No Abstract]   [Full Text] [Related]  

  • 11. Blue Cross and Blue Shield Plan contracts with providers: cost containment objectives amid conflicting legislative schemes.
    Heitler G; Ader M
    J Leg Med; 1981 Sep; 2(3):265-96. PubMed ID: 6976401
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitrust assault on hospital-Blue Cross relations.
    Davis CD
    Tex Hosp; 1984 Feb; 39(9):46-7. PubMed ID: 10278223
    [No Abstract]   [Full Text] [Related]  

  • 13. Vertical restraints and powerful health insurers: exclusionary conduct masquerading as managed care?
    Miller FH
    Law Contemp Probl; 1988; 51(2):195-236. PubMed ID: 10295963
    [No Abstract]   [Full Text] [Related]  

  • 14. Examining exclusionary conduct of HMOs and PPOs: a case comment on Northwest Medical Laboratories v. Blue Cross and Blue Shield of Oregon.
    Levitt DM
    Am J Law Med; 1991; 17(3):271-88. PubMed ID: 1785621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitrust implications of health planning: National Gerimedical Hospital and Gerontology Center v. Blue Cross of Kansas City.
    Chase JB
    Am J Law Med; 1982; 8(3):321-48. PubMed ID: 7168454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U.S. District Court finds Blue Shield physician payment method violates Sec. 1 of the Sherman Act.
    Laurence K; Kinney ED
    Health Law Vigil; 1984 Mar; 7(7):4-7. PubMed ID: 10278231
    [No Abstract]   [Full Text] [Related]  

  • 17. Court upholds Blues' fee discounts.
    Burda D
    Mod Healthc; 1989 Sep; 19(35):3. PubMed ID: 10324683
    [No Abstract]   [Full Text] [Related]  

  • 18. Must payers deal with their vertically integrated competitors--the Wesley Medical Center decision.
    Miles JJ
    Health Law Vigil; 1986 Aug; 9(15):11-4. PubMed ID: 10278408
    [No Abstract]   [Full Text] [Related]  

  • 19. Toledo Hospital, Blue Cross plan in $2.5 billion suit.
    Robinson ML
    Hospitals; 1988 Aug; 62(15):28-9. PubMed ID: 3391564
    [No Abstract]   [Full Text] [Related]  

  • 20. FTC eyes ban of M.D. input into HMOs, Blues.
    Mod Healthc; 1979 Dec; 9(12):32. PubMed ID: 503022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.